MBP and myeloid sarcoma: Moreover, structural studies revealed the cross-reactivity of EBNA-1-specific T-cells to the N-terminal of MBP (residue 85-99) (55, 64), suggesting that the elevated level of these T-cells may target the MBP, which could provoke MS pathogenesis.